BioLASCO Taiwan Co., Ltd. (TPEX:6662)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
28.60
+0.05 (0.18%)
May 29, 2026, 1:30 PM CST
Market Cap732.50M -15.6%
Revenue (ttm)263.81M -13.4%
Net Income43.39M -3.4%
EPSn/a
Shares Out 25.61M
PE Ratio16.88
Forward PEn/a
Dividend1.50 (5.24%)
Ex-Dividend DateAug 7, 2025
Volume4,000
Open29.00
Previous Close28.55
Day's Range28.60 - 29.00
52-Week Range28.00 - 35.80
Beta0.23
Analystsn/a
Price Targetn/a
Earnings DateMar 27, 2026

About BioLASCO Taiwan

BioLASCO Taiwan Co., Ltd. operates an animal breeding center to produce specific pathogen-free laboratory mice and rats in Taiwan and internationally. It offers lab animals, such as rat, mice, and others, as well as surgical services; rodents housing, washing solutions, workstations, animal housing and management solutions, lab animal research equipment, clean solution, preclinical imaging system, and experimental equipment; various reagents, including lab animal diagnostic reagent, endotoxin testing system, portable endotoxin testing system, r... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1990
Employees 91
Stock Exchange Taipei Exchange
Ticker Symbol 6662
Full Company Profile

Financial Performance

In 2025, BioLASCO Taiwan's revenue was 262.66 million, a decrease of -10.20% compared to the previous year's 292.50 million. Earnings were 42.43 million, a decrease of -3.63%.

Financial Statements